GE HealthCare: EPS up 9% in Q2

(CercleFinance.com) - GE HealthCare reports Q2 2024 adjusted EPS that is up almost 9% to exactly $1, with an adjusted operating margin that improved 0.
6 point to 15.3%, seeing the benefits of productivity and pricing gains. NB: pmt -3.4%.

At $4.84bn, the medical technology group's revenues were flat as reported, but up 1% organically, with 3% organic growth in orders enabling a solid book-to-bill ratio of 1.06.

GE Healthcare confirms its annual adjusted EPS target range of $4.20 to $4.35, with its adjusted EBIT margin expected to increase to 15.7%-16%, with organic revenue growth falling to +1% to +2%, due to headwinds in China.


Copyright (c) 2024 CercleFinance.com. All rights reserved.